Table 2:
Expected capacity (i.e., yes, no) of typical early preliminary (Pre) and full cost-utility analysis (CUA) to address the 19-item Consensus Health Economic Criteria (CHEC) extended checklist.
| Item | Questions | CUA | ||
|---|---|---|---|---|
| Early | Pre | Full | ||
| 1 | Is the study population clearly described? | Yes | Yes | Yes |
| 2 | Are competing alternatives clearly described? | Yes | Yes | Yes |
| 3 | Is a well-defined research question posed in answerable form? | Yes | Yes | Yes |
| 4 | Is the economic study design appropriate to the stated objective? | Yes | Yes | Yes |
| 5 | Is the chosen time horizon appropriate in order to include relevant costs and consequences? | No | No | Yes |
| 6 | Is the actual perspective chosen appropriate? | Yes | Yes | Yes |
| 7 | Are all important and relevant costs for each alternative identified? | No | No | Yes |
| 8 | Are all costs measured appropriately in physical units? | Yes | Yes | Yes |
| 9 | Are costs valued appropriately? | No | No | Yes |
| 10 | Are all important and relevant outcomes for each alternative identified? | No | No | Yes |
| 11 | Are all outcomes measured appropriately? | No | No | Yes |
| 12 | Are outcomes valued appropriately? | No | No | Yes |
| 13 | Is an incremental analysis of costs and outcomes of alternatives performed? | No | Yes | Yes |
| 14 | Are all future costs and outcomes discounted appropriately? | No | No | Yes |
| 15 | Are all important variables, whose values are uncertain, appropriately subjected to sensitivity analysis? | No | No | Yes |
| 16 | Do the conclusions follow from the data reported? | Yes | Yes | Yes |
| 17 | Does the study discuss the generalizability of the results to other settings and patient/client groups? | Yes | Yes | Yes |
| 18 | Does the article indicate that there is no potential conflict of interest of study researcher(s) and funder(s)? | Yes | Yes | Yes |
| 19 | Are ethical and distributional issues discussed appropriately? | Yes | Yes | Yes |